Volume 115, Issue 1 pp. 66-68

Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy

Ulka N. Vaishampayan

Ulka N. Vaishampayan

Division of Hematology Oncology, Department of Medicine, Wayne State University/Barbara Ann Karmanos Cancer Institute, Detroit, MI,

Search for more papers by this author
Anwar N. Mohamed

Anwar N. Mohamed

Department of Pathology and Cytogenetics Laboratory,
Wayne State University/Detroit, MI,

Search for more papers by this author
Michael C. Dugan

Michael C. Dugan

Department of Pathology, Santa Monica UCLA Medical Center, Santa Monica, CA, and

Search for more papers by this author
Robert E. Bloom

Robert E. Bloom

Division of Hematology/Oncology, Department of Medicine, Grace-Sinai Hospital, Wayne State University/Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA

Search for more papers by this author
Margarita Palutke

Margarita Palutke

Department of Pathology and Cytogenetics Laboratory,
Wayne State University/Detroit, MI,

Search for more papers by this author
First published: 09 August 2008
Citations: 34
Margarita Palutke, MD, Core Hematology, University Laboratories, 4201 St Antoine, Detroit, MI 48201, USA. E-mail: [email protected]

Abstract

Two elderly men with stage IV mantle cell lymphoma (MCL) rapidly developed a leukaemic phase with unusually high blast counts that proved fatal. One lymph node biopsy showed diffuse MCL, the other blastic morphology. In addition to t(11;14), there were t(8;14) and t(1;19) in case 1 and dup(8)(q24q13) in case 2. Fluorescence in situ hybridization revealed genomic fusion of IgH/MYC genes in case 1 and an extra copy of C-MYC gene in case 2. The genomic alteration of C-MYC oncogene is probably implicated in the blastic transformation and aggressive behaviour of the disease.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.